Literature DB >> 19719953

Hepatitis B virus in tenofovir-naive Chinese patients with chronic hepatitis B contains no mutation of rtA194T conferring a reduced tenofovir susceptibility.

Yan Liu1, Chun-mei Wang, Jun Cheng, Zhao-ling Liang, Yan-wei Zhong, Xiao-qiang Ren, Zhi-hui Xu, Fabien Zoulim, Dong-ping Xu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19719953

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  9 in total

1.  Association between hepatitis B virus basal core promoter/precore region mutations and the risk of hepatitis B-related acute-on-chronic liver failure in the Chinese population: an updated meta-analysis.

Authors:  Xueyuan Nian; Zhihui Xu; Yan Liu; Jianhong Chen; Xiaodong Li; Dongping Xu
Journal:  Hepatol Int       Date:  2016-03-16       Impact factor: 6.047

2.  Hepatitis B virus (HBV) subgenotypes C2 and B2 differ in lamivudine- and adefovir-resistance-associated mutational patterns in HBV-infected Chinese patients.

Authors:  Xiaodong Li; Lin Wang; Yanwei Zhong; Vincent Wai-Sun Wong; Zhihui Xu; Yan Liu; Qinghong Li; Shaojie Xin; Jingmin Zhao; Dongping Xu
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

3.  Detection and analysis of resistance mutations of hepatitis B virus.

Authors:  Xiaohong He; Fang Wang; Bin Huang; Peisong Chen; Liangying Zhong
Journal:  Int J Clin Exp Med       Date:  2015-06-15

4.  Hepatitis B virus DNA polymerase gene polymorphism based prediction of genotypes in chronic HBV patients from Western India.

Authors:  Yashwant G Chavan; Sharad R Pawar; Minal Wani; Amol D Raut; Rabindra N Misra
Journal:  Afr Health Sci       Date:  2017-09       Impact factor: 0.927

5.  Efficacy and Safety of Tenofovir Disoproxil Treatment for Chronic Hepatitis B Patients with Genotypic Resistance to Other Nucleoside Analogues: A Prospective Study.

Authors:  Jing Zhou; Yue-Ying Liu; Jiang-Shan Lian; Li-Fang Pan; Jian-Le Yang; Jian-Rong Huang
Journal:  Chin Med J (Engl)       Date:  2017-04-20       Impact factor: 2.628

6.  Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure.

Authors:  Zhihui Xu; Xiaoqiang Ren; Yan Liu; Xiaodong Li; Siyu Bai; Yanwei Zhong; Lin Wang; Panyong Mao; Huifen Wang; Shaojie Xin; Vincent Wai-Sun Wong; Henry Lik-Yuen Chan; Fabien Zoulim; Dongping Xu
Journal:  J Gastroenterol       Date:  2010-09-17       Impact factor: 7.527

7.  Hepatitis B virus genotype and basal core promoter/precore mutations are associated with hepatitis B-related acute-on-chronic liver failure without pre-existing liver cirrhosis.

Authors:  X Ren; Z Xu; Y Liu; X Li; S Bai; N Ding; Y Zhong; L Wang; P Mao; F Zoulim; D Xu
Journal:  J Viral Hepat       Date:  2010-12       Impact factor: 3.728

8.  Dynamic changes of HBV markers and HBV DNA load in infants born to HBsAg(+) mothers: can positivity of HBsAg or HBV DNA at birth be an indicator for HBV infection of infants?

Authors:  Tianyan Chen; Jing Wang; Yuling Feng; Zhi Yan; Tieying Zhang; Minghui Liu; Yun Bai; Hongxia Song; Hongli Liu; Yuan Yang; Jinfeng Liu; Yingli He; Yunru Chen; Shulin Zhang; Guihua Zhuang; Xiaofeng Liang; Zongyin Liu; Xiaguang Xu; Wei Chen; Yong Liu; Yingren Zhao
Journal:  BMC Infect Dis       Date:  2013-11-06       Impact factor: 3.090

9.  Profile of hepatitis B virus resistance mutations against nucleoside/nucleotide analogue treatment in Chinese patients with chronic hepatitis B.

Authors:  Jun Lei; Ying Wang; Li-Li Wang; Shao-Jun Zhang; Wei Chen; Zhi-Gang Bai; Lv-Ye Xu
Journal:  Virol J       Date:  2013-10-25       Impact factor: 4.099
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.